SCHEMBL890923

SCHEMBL890923

SCOc1ccc(OCS)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.47
HDAC6 Q9UBN7 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
IDO1 P14902 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KCNA3 P22001 1/20 0.36
APP P05067 1/20 0.36
LTA4H P09960 4/20 0.35
PRSS1 P07477 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867839 0.88 NQO1 (0.39) NQO1HDAC6HDAC3HDAC4HDAC1
SCHEMBL3943214 0.86 IDO1 (0.58) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL6570979 0.86 APP (0.47) APPLTA4HLMNAPTGS2L3MBTL1
SCHEMBL2494430 0.86 NQO1 (0.38) NQO1HDAC6HDAC3HDAC4HDAC1
SCHEMBL4460174 0.86 LTA4H (0.52) HDAC6APPLTA4HLMNACYP1A2
SCHEMBL17012191 0.86 MAOB (0.47) IDO1TDP1APPCYP1A2CYP2C19
SCHEMBL5828143 0.86 TDP1 (0.58) TSHRTDP1APPL3MBTL1
SCHEMBL4710446 0.84
SCHEMBL3130649 0.84 NQO1 (0.36) NQO1HDAC6HDAC3HDAC4HDAC1
SCHEMBL7102077 0.80 ALDH1A1 (0.52) LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION KUREHA CORPORATION (JP) 2026-03-05 US disclosed
US-20260062512-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT KUREHA CORPORATION (JP) 2026-03-05 US disclosed
EP-4679147-A1 MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS TOKUYAMA CORPORATION (JP) 2026-01-14 EP disclosed
US-20250355282-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-11-20 US disclosed
US-20250257162-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2025-08-14 US disclosed
EP-4582463-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT Kureha Corporation (JP) 2025-07-09 EP disclosed
EP-4582459-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION Kureha Corporation (JP) 2025-07-09 EP disclosed
EP-4560367-A1 LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-05-28 EP disclosed
CN-119768447-A Curable composition, cured product, and method for producing cured product 株式会社吴羽 2025-04-04 CN disclosed
CN-119768439-A Rubber-bonded cellulose fiber, method for producing same, resin composition, method for producing same, and cured resin composition 株式会社吴羽 2025-04-04 CN disclosed
EP-0751161-B1 Sulfur-containing urethane-based resin composition, optical element and lens comprising this resin MITSUI CHEMICALS INC (JP) 2003-01-02 EP disclosed
US-20020132954-A1 Optical materials having good ultraviolet absorbability and method for producing them KOSAKA MASAHISA (JP) 2002-09-19 US disclosed
US-6448304-B1 POLYURETHANE, POLYTHIOURETHANE OR DIETHYLENE GLYCOL BISALLYLCARBONATE POLYMER; DIPPING IN SOLUTION CONTAINING A DIBENZOYLMETHANE OR A BENZOTRIZOLE COMPOUND; PLASTIC LENS FOR SPECTACLES WHICH ABSORBS ULTRAVIOLET RAYS; LOW YELLOWNESS HOYA CORPORATION (JP) 2002-09-10 US disclosed
US-6441119-B1 POLYMERIZING A PLASTIC LENS MONOMER SUCH AS A DIETHYLENE GLYCOL, BISALLYL CARBONATE MIXED WITH THE UV ABSORBENT 2-(2-HYDROXY-4-OCTYLOXYPHENYL)-BENZOTRIAZOLE; NONYELLOWING; EYEGLASSES HOYA CORPORATION (JP) 2002-08-27 US disclosed
EP-1085348-A2 Plastic lenses of good ultraviolet absorbability for spectacles and method for producing them HOYA CORPORATION (JP) 2001-03-21 EP disclosed
EP-1085349-A2 Plastic lenses having good ultraviolet absorbability, and method for the production thereof HOYA CORPORATION (JP) 2001-03-21 EP disclosed
US-5955206-A POLYTHIOETHERS AND ACRYLATE OR VINYL GROUPS FOR CURING TO FORM OPTICAL LENSES MITSUI CHEMICALS, INC. (JP) 1999-09-21 US disclosed
US-5736609-A A POLYTHIO COMPOUND CONTAINING AT LEAST TWO MERCAPTO GROUPS, A POLYISO(THIO)CYANATE COMPOUND, AND A COMPOUND HAVING TWO OR MORE UNSATURATED REACTIVE GROUPS MITSUI TOATSU CHEMICALS, INC. (JP) 1998-04-07 US disclosed
EP-0751161-A2 Sulfur-containing urethane-based resin composition, optical element and lens comprising this resin MITSUI TOATSU CHEMICALS, Inc. (JP) 1997-01-02 EP disclosed
EP-0742244-A2 Durable polysulfide composition for optical material MITSUI TOATSU CHEMICALS, INC. (JP) 1996-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION CROCC, WASF2, DCXR NQO1 2240/4885HDAC6 1764/4885HDAC3 3427/4885
US-20260062512-A1 CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT EHMT1, EHMT2, ASH2L NQO1 2486/4885HDAC6 1887/4885HDAC3 1832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.